Advanced search
Publication Cover
Postgraduate Medicine Volume 114, 2003 - Issue 1
Submit an article Journal homepage
8
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Current therapies for chronic hepatitis C

Drug combination achieves sustained response in more than half of patients

Keyur Patel Dr Patel is a senior research associate, and Dr McHutchison is director, gastrointestinal and hepatology research, Duke Clinical Research Institute, division of gastroenterology, Duke University Medical Center, Durham, North Carolina.
, MD &
John G. McHutchison Dr Patel is a senior research associate, and Dr McHutchison is director, gastrointestinal and hepatology research, Duke Clinical Research Institute, division of gastroenterology, Duke University Medical Center, Durham, North Carolina.Correspondence[email protected].
, MD
Pages 48-62 | Published online: 30 Jun 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Janetta M. Astone, Shiela M. Strauss, Holly Hagan & Don C. Des Jarlais. (2004) Outpatient Drug Treatment Program Directors' Hepatitis C‐Related Beliefs and Their Relationship to the Provision of HCV Services. The American Journal of Drug and Alcohol Abuse 30:4, pages 783-797.
Read now

Articles from other publishers (3)

Emilio Palumbo. (2010) Pegylated interferon and ribavirin treatment for hepatitis C virus infection. Therapeutic Advances in Chronic Disease 2:1, pages 39-45.
Crossref
Emilio Palumbo. (2009) Peg-Interferon in Acute and Chronic Hepatitis C: A Review. American Journal of Therapeutics 16:6, pages 573-578.
Crossref
Poonam Mishra & Donald M. Jensen. (2008) Hepatitis C: current and future therapies. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:4, pages 405-414.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.